Literature DB >> 31905333

Refining the Definition of Polypharmacy and Its Link to Disability in Older Adults: Conceptualizing Necessary Polypharmacy, Unnecessary Polypharmacy, and Polypharmacy of Unclear Benefit.

Eric A Lee1, Jeffrey W Brettler1, Michael H Kanter2, Steven G Steinberg3, Peter Khang4, Christopher C Distasio5, John Martin6, Mark Dreskin7,8, Nolan H Thompson9, Timothy M Cotter10, Kim Thai11, Lyn Yasumura12, Nancy E Gibbs13.   

Abstract

The term polypharmacy in older adults is generally used in a pejorative context in the medical literature. Because of its link to geriatric syndromes and disability, the avoidance of polypharmacy is usually recommended in older adults as a strategy to optimize functional status. However, there are many polypharmacy regimens based on high-quality trials that clearly reduce the risk of disability in older adults. Other guidelines for older adults recommend the use of additional medications that may or may not be evidence based and that may or may not reduce disability. Therefore, we propose that, in the geriatric literature, polypharmacy now be categorized as "necessary polypharmacy," "unnecessary polypharmacy," or "polypharmacy of unclear benefit." In this article, we discuss the 3 categories of polypharmacy and give examples on each polypharmacy regimen and its potential relationship to disability in older adults.

Entities:  

Mesh:

Year:  2019        PMID: 31905333      PMCID: PMC6972545          DOI: 10.7812/TPP/18.212

Source DB:  PubMed          Journal:  Perm J        ISSN: 1552-5767


  51 in total

1.  AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation.

Authors:  Sidney C Smith; Emelia J Benjamin; Robert O Bonow; Lynne T Braun; Mark A Creager; Barry A Franklin; Raymond J Gibbons; Scott M Grundy; Loren F Hiratzka; Daniel W Jones; Donald M Lloyd-Jones; Margo Minissian; Lori Mosca; Eric D Peterson; Ralph L Sacco; John Spertus; James H Stein; Kathryn A Taubert
Journal:  Circulation       Date:  2011-11-03       Impact factor: 29.690

Review 2.  Delirium in older persons.

Authors:  Sharon K Inouye
Journal:  N Engl J Med       Date:  2006-03-16       Impact factor: 91.245

3.  Osteoporosis disease management: What every orthopaedic surgeon should know.

Authors:  Richard M Dell; Denise Greene; David Anderson; Kathy Williams
Journal:  J Bone Joint Surg Am       Date:  2009-11       Impact factor: 5.284

4.  Risk of Injury in Older Adults Using Gastrointestinal Antispasmodic and Anticholinergic Medications.

Authors:  Michele M Spence; Fatima A Karim; Eric A Lee; Rita L Hui; Nancy E Gibbs
Journal:  J Am Geriatr Soc       Date:  2015-06-11       Impact factor: 5.562

Review 5.  Gabapentin for chronic neuropathic pain in adults.

Authors:  Philip J Wiffen; Sheena Derry; Rae F Bell; Andrew Sc Rice; Thomas Rudolf Tölle; Tudor Phillips; R Andrew Moore
Journal:  Cochrane Database Syst Rev       Date:  2017-06-09

6.  Duration of Antibiotic Treatment in Community-Acquired Pneumonia: A Multicenter Randomized Clinical Trial.

Authors:  Ane Uranga; Pedro P España; Amaia Bilbao; Jose María Quintana; Ignacio Arriaga; Maider Intxausti; Jose Luis Lobo; Laura Tomás; Jesus Camino; Juan Nuñez; Alberto Capelastegui
Journal:  JAMA Intern Med       Date:  2016-09-01       Impact factor: 21.873

Review 7.  Delirium in elderly adults: diagnosis, prevention and treatment.

Authors:  Tamara G Fong; Samir R Tulebaev; Sharon K Inouye
Journal:  Nat Rev Neurol       Date:  2009-04       Impact factor: 42.937

8.  Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011.

Authors:  Amit S Chitnis; Stacy M Holzbauer; Ruth M Belflower; Lisa G Winston; Wendy M Bamberg; Carol Lyons; Monica M Farley; Ghinwa K Dumyati; Lucy E Wilson; Zintars G Beldavs; John R Dunn; L Hannah Gould; Duncan R MacCannell; Dale N Gerding; L Clifford McDonald; Fernanda C Lessa
Journal:  JAMA Intern Med       Date:  2013-07-22       Impact factor: 21.873

Review 9.  CDC Guideline for Prescribing Opioids for Chronic Pain--United States, 2016.

Authors:  Deborah Dowell; Tamara M Haegerich; Roger Chou
Journal:  JAMA       Date:  2016-04-19       Impact factor: 56.272

10.  The Risk of Pneumonia in Older Adults Using Nonbenzodiazepine Hypnotics.

Authors:  Stephen Jung; Michele M Spence; Nina M Escasa; Eric A Lee; Rita L Hui; Nancy E Gibbs
Journal:  J Manag Care Spec Pharm       Date:  2016-08
View more
  4 in total

1.  Anticholinergic drug burden according to the anticholinergic drug scale and the German anticholinergic burden and their impact on cognitive function in multimorbid elderly German people: a multicentre observational study.

Authors:  Caroline Krüger; Ingmar Schäfer; Hendrik van den Bussche; Horst Bickel; Angela Fuchs; Jochen Gensichen; Hans-Helmut König; Wolfgang Maier; Karola Mergenthal; Steffi G Riedel-Heller; Gerhard Schön; Siegfried Weyerer; Birgitt Wiese; Wolfgang von Renteln-Kruse; Claudia Langebrake; Martin Scherer
Journal:  BMJ Open       Date:  2021-03-23       Impact factor: 2.692

2.  Predictors of Polypharmacy Among Elderly Patients in China: The Role of Decision Involvement, Depression, and Taking Chinese Medicine Behavior.

Authors:  Chaoyi Chen; Zhanchun Feng; Qian Fu; Jia Wang; Zehao Zheng; Hao Chen; Da Feng
Journal:  Front Pharmacol       Date:  2021-12-06       Impact factor: 5.810

Review 3.  Polypharmacy among COVID-19 patients: A systematic review.

Authors:  Sorochi Iloanusi; Osaro Mgbere; Ekere J Essien
Journal:  J Am Pharm Assoc (2003)       Date:  2021-05-26

4.  Non-random relations in drug use expressed as patterns comprising prescription and over-the-counter drugs in multimorbid elderly patients in primary care: Data of the exploratory analysis of the multicentre, observational cohort study MultiCare.

Authors:  Caroline Krüger; Ingmar Schäfer; Hendrik van den Bussche; Michael Baehr; Horst Bickel; Angela Fuchs; Jochen Gensichen; Wolfgang Maier; Steffi G Riedel-Heller; Hans-Helmut König; Anne Dahlhaus; Gerhard Schön; Siegfried Weyerer; Birgitt Wiese; Wolfgang von Renteln-Kruse; Claudia Langebrake; Martin Scherer
Journal:  Eur J Gen Pract       Date:  2021-12       Impact factor: 1.904

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.